MARTELLUCCI, IGNAZIO
 Distribuzione geografica
Continente #
NA - Nord America 1.764
EU - Europa 1.493
AS - Asia 968
SA - Sud America 123
AF - Africa 40
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.392
Nazione #
US - Stati Uniti d'America 1.728
RU - Federazione Russa 384
SG - Singapore 336
GB - Regno Unito 307
CN - Cina 280
IE - Irlanda 182
IT - Italia 174
VN - Vietnam 134
BR - Brasile 98
UA - Ucraina 88
SE - Svezia 86
FR - Francia 85
DE - Germania 80
HK - Hong Kong 72
FI - Finlandia 47
BD - Bangladesh 46
KR - Corea 29
IN - India 25
ZA - Sudafrica 24
CA - Canada 21
ES - Italia 13
MX - Messico 11
IQ - Iraq 8
NL - Olanda 8
TR - Turchia 8
BE - Belgio 7
PL - Polonia 7
VE - Venezuela 7
LT - Lituania 6
CI - Costa d'Avorio 5
IL - Israele 5
PE - Perù 5
AR - Argentina 4
CO - Colombia 4
JP - Giappone 4
NG - Nigeria 4
PK - Pakistan 4
AT - Austria 3
AO - Angola 2
AZ - Azerbaigian 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
HR - Croazia 2
IR - Iran 2
PA - Panama 2
PT - Portogallo 2
QA - Qatar 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AU - Australia 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
FJ - Figi 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
ID - Indonesia 1
KI - Kiribati 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
MT - Malta 1
MY - Malesia 1
PH - Filippine 1
RO - Romania 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 4.392
Città #
Southend 262
Singapore 204
Dallas 189
Dublin 178
Fairfield 175
Ashburn 149
San Jose 104
Moscow 100
Santa Clara 86
Woodbridge 86
Chandler 84
Beijing 83
Seattle 76
Jacksonville 72
Houston 69
Hong Kong 68
Wilmington 63
Cambridge 48
Ann Arbor 44
Ho Chi Minh City 44
Siena 42
New York 40
Hanoi 37
Hefei 37
Los Angeles 34
Princeton 31
Council Bluffs 30
Munich 30
Nanjing 30
Seoul 29
Helsinki 25
Johannesburg 22
Milan 22
Lauterbourg 21
Shanghai 19
Rome 14
The Dalles 13
Boardman 12
San Diego 12
San Mateo 12
Florence 11
London 11
São Paulo 10
Málaga 9
Chicago 8
Denver 8
Toronto 8
Turku 8
Brussels 7
Montreal 7
Nanchang 7
Warsaw 7
Amsterdam 6
Bologna 6
Buffalo 6
Da Nang 6
Dearborn 6
Düsseldorf 6
Abidjan 5
Baghdad 5
Boston 5
Catania 5
Haiphong 5
Nuremberg 5
Orem 5
Redondo Beach 5
San Francisco 5
Abuja 4
Ankara 4
Belo Horizonte 4
Bengaluru 4
Brooklyn 4
Cagliari 4
Changsha 4
Chennai 4
Dong Ket 4
Frankfurt am Main 4
Hebei 4
Naples 4
Ningbo 4
Poplar 4
Renton 4
Washington 4
Aguascalientes 3
Atlanta 3
Can Tho 3
Curitiba 3
Fremont 3
Hangzhou 3
Kunming 3
Lima 3
Manchester 3
Mexico City 3
Mumbai 3
Paris 3
Phoenix 3
Stockholm 3
Tianjin 3
Tokyo 3
Vinci 3
Totale 2.993
Nome #
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients 341
Efficacy and Safety of Regorafenib With 2/1 Schedule for Patients ≥ 75 Years With Metastatic Colorectal Cancer (mCRC) After Failure of 2 Lines of Chemotherapy 320
A62Effectiveness and resulting surgical behavior after neoadjuvant chemotherapy in locally advanced breast cancer: our experience 313
A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients 261
Cisplatin, etoposide, and bevacizumab regimen followed by oral etoposide and bevacizumab maintenance treatment in patients with extensive-stage small cell lung cancer: A single-institution experience 261
Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab and has strong antitumor activity in advanced non-small-cell-lung cancer patients 256
Two-point-NGS analysis of cancer genes in cell-free DNA of metastatic cancer patients 255
Bevacizumab and weekly Doxetacel in patients with metastatic castrate-resistant prostate cancer previously exposed to Docetaxel 242
Effects of intravenous Zoledronic acid and oral ibandronate on early changes in markers of bone turnover in patients with bone metastases from NSCLC 222
Metronomic antiangiogenetic biochemotherapy of non-small cell lung cancer patients with fractioned cisplatinum, oral etoposide and bevacizumab: phase IB/II study 212
Thymidine phosphorylase expression in metastatic sites is predictive for response in patients with colorectal cancer treated with continuous oral capecitabine and biweekly oxaliplatin 211
Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients 211
Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial) 208
First-line pharmacotherapies and survival among patients diagnosed with non-resectable NSCLC: a real-life setting study with gender prospective 171
Porcelain gallbladder and its relationship to cancer 170
Metronomic antiangiogenetic biochemotherapy of non-small cell lung cancer patients with fractionated cisplatimum, oral etoposide, and bevacizumab 163
Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancer 163
Sjögren's syndrome and aromatase inhibitors treatment: is there a link? 138
Head and Neck Carcinoma and biomarker profiling: searching tumor identity card. 122
Head and Neck Carcinoma and biomarker profiling: searching tumor identity card. 82
Rare variants modulating phenotype in NF1 carriers 80
Early psychological intervention in cancer patients: effects on emotional distress 30
Longitudinal Whole-Exome Sequencing of Cell-Free DNA Reveals Molecular Evolution and Heterogeneous Clinical Outcomes in PD-L1 Stratified Advanced NSCLC Adenocarcinoma Patients Treated with Atezolizumab 12
null 3
Totale 4.447
Categoria #
all - tutte 13.468
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.468


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 0 0 0 0 0 0 0 0 23
2021/2022253 22 20 14 19 15 11 9 10 12 31 33 57
2022/2023319 21 23 47 40 27 63 5 29 33 10 14 7
2023/2024293 5 5 24 13 10 88 105 9 3 12 3 16
2024/2025600 33 27 63 38 73 33 8 19 74 27 77 128
2025/20261.786 107 189 147 232 386 97 212 66 54 116 107 73
Totale 4.447